Who really owns your skincare brand

Five conglomerates own almost every skincare brand sold in drugstores. Here’s the full ownership map and why it matters for your skin.

Five companies own nearly every skincare brand in the United States.

The skincare aisle creates an illusion of choice. Dozens of brands, different packaging, different price points — but trace the ownership and five parent corporations control the majority of what consumers buy. Understanding who owns what reveals structural conflicts of interest in how products are formulated.

---

L’Oréal Group

Headquarters: Paris, France Annual Revenue: $44+ billion (2023) Subsidiaries relevant to skincare:

Brand	Category	Price Point
CeraVe	Drugstore sensitive skin	$12-20
La Roche-Posay	Dermatologist-recommended	$20-45
Kiehl’s	Premium natural-positioned	$30-70
Lancôme	Luxury/prestige	$40-150+
Garnier	Mass market	$6-15
IT Cosmetics	Color + skincare	$25-60
SkinCeuticals	Professional/clinical	$50-180
Vichy	Pharmacy skincare	$20-50
Urban Decay	Color cosmetics	$15-55
NYX	Affordable cosmetics	$5-20

The conflict: L’Oréal owns both the $12 CeraVe cleanser that contains sulfates and the$45 La Roche-Posay “gentle” alternative. Both brands target sensitive skin. One strips the barrier; the other repairs it. The same corporation profits from both sides of the damage cycle.

Formulation implications: CeraVe’s moisturizers contain phenoxyethanol and petrolatum. La Roche-Posay markets itself as dermatologist-first but shares manufacturing infrastructure with L’Oréal’s mass-market lines. Ingredient sourcing decisions flow through a single corporate procurement department optimizing for margin, not for individual brand missions.

---

Johnson & Johnson (Kenvue)

Headquarters: New Brunswick, New Jersey Annual Revenue: $85+ billion (2023, combined J&J + Kenvue) Note: J&J spun off consumer health as Kenvue in 2023. Same brands, same formulations, new corporate name.

Brand	Category	Price Point
Neutrogena	Mass market dermatologist-positioned	$8-30
Aveeno	Natural-positioned mass market	$8-25
Clean & Clear	Teen/acne	$5-12
Lubriderm	Basic body moisture	$6-12
RoC	Anti-aging retinol	$20-40
Johnson’s Baby	Infant care	$4-10
Ambi	Skin lightening	$5-10
Listerine	Oral care	—
Band-Aid	Wound care	—

The conflict: Johnson & Johnson marketed baby shampoo containing formaldehyde-releasing preservatives (quaternium-15) for decades. After public pressure, they reformulated in 2014 — but only in certain markets. The company faced a $2.1 billion talc-related cancer verdict in 2018. Their consumer health division (now Kenvue) continues selling products containing SLS, synthetic fragrance, and DMDM hydantoin.

Formulation implications: Neutrogena positions itself as “dermatologist-recommended” while using sodium lauryl sulfate in facial cleansers. Aveeno positions as “natural” while containing phenoxyethanol, dimethicone, and synthetic fragrance in select products. J&J’s pharmaceutical division develops prescription eczema treatments while its consumer division sells OTC products containing ingredients that trigger eczema flares.

---

Procter & Gamble

Headquarters: Cincinnati, Ohio Annual Revenue: $84+ billion (2023)

Brand	Category	Price Point
Olay	Mass market anti-aging	$10-50
SK-II	Luxury Japanese skincare	$80-300+
Gillette	Shaving/grooming	$5-40
Old Spice	Men’s grooming	$5-15
Pantene	Hair care	$4-10
Head & Shoulders	Medicated shampoo	$5-12
Herbal Essences	Natural-positioned hair	$5-10

The conflict: P&G sells Olay at $10-50 and SK-II at$80-300+ using fundamentally similar active categories (niacinamide, peptides, fermented ingredients). The 10x price difference reflects branding and marketing investment, not proportional ingredient quality differences. P&G’s R&D is centralized — breakthroughs developed for SK-II could improve Olay formulations, but that would cannibalize premium revenue.

Formulation implications: Olay products contain synthetic dyes (FD&C colors), synthetic fragrances, and petrochemical emollients. The corporation’s optimization target is margin-per-unit, not ingredient purity. Products are formulated to perform “good enough” at each price point without cannibalizing the tier above.

---

Estée Lauder Companies

Headquarters: New York, New York Annual Revenue: $15+ billion (2023)

Brand	Category	Price Point
The Ordinary (DECIEM)	Affordable actives	$5-15
Clinique	Prestige dermatologist-positioned	$25-80
Origins	Natural/plant-based prestige	$20-60
Bobbi Brown	Luxury color + skin	$30-100
MAC	Professional cosmetics	$15-60
Aveda	Plant-based hair/body	$20-50
La Mer	Ultra-luxury	$90-500+
Bumble and bumble	Professional hair	$25-50
Dr. Jart+	K-beauty clinical	$15-60

The conflict: Estée Lauder owns The Ordinary ($7 niacinamide serum) and La Mer ($200+ moisturizer). The Ordinary is positioned as “transparent, no-markup actives” — yet the same parent company charges 30x more for comparable active ingredients under the La Mer label. The Ordinary’s brand messaging critiques the industry its parent company leads.

Formulation implications: The Ordinary uses phenoxyethanol, chlorphenesin, and synthetic polymers throughout its range. The brand is not certified organic and contains no organic ingredients. Despite positioning as “transparent,” ingredient sourcing and manufacturing details remain corporate-controlled through Estée Lauder’s supply chain.

---

Beiersdorf

Headquarters: Hamburg, Germany Annual Revenue: $9+ billion (2023)

Brand	Category	Price Point
Nivea	Mass market moisturizer	$5-15
Eucerin	Pharmacy sensitive skin	$10-30
Aquaphor	Healing/barrier repair	$8-20
La Prairie	Ultra-luxury Swiss	$150-1,000+
Coppertone	Sun protection	$8-15

The conflict: Beiersdorf sells Aquaphor (41% petrolatum at $8) and La Prairie (plant stem cell technology at$500+). Eucerin is marketed for sensitive and eczema-prone skin but formulations contain mineral oil, synthetic fragrance (in select products), and petrochemical occlusives. The same company owns the $8 petroleum jelly product and the$500 anti-aging cream.

Formulation implications: Aquaphor’s primary ingredient is petrolatum — a petroleum refining byproduct that creates occlusion without delivering active skin-healing nutrients. For eczema (Eucerin’s target market), occlusion without active repair ingredients creates symptom management without supporting actual barrier recovery.

---

What independent ownership means

Era Organics is owned by Nikki Chase. No parent corporation. No sister brands. No conflicting financial incentives.

What this means for formulation:

• No tiered ingredient strategy. Era Organics does not reserve better ingredients for a premium sub-brand. Every product gets the best formulation possible.
• No barrier-damage incentive. Era Organics does not sell cleansers that strip the barrier AND moisturizers that repair it. Every product in the line is formulated to support skin health — not create dependency on another product.
• No marketing-first formulation. Ingredient decisions are driven by efficacy and safety data, not by corporate margin targets or competitive positioning against sister brands.
• Full supply chain control. Ingredient sourcing decisions are made by the formulator, not by a corporate procurement department optimizing for cost across 20+ brands.

---

FAQ

Does corporate ownership actually affect product quality?

Corporate ownership affects formulation priorities. A brand owned by a conglomerate must justify its existence relative to sister brands at different price points. This creates structural pressure to differentiate through marketing rather than formulation — using cheaper ingredients at lower price points and reserving premium ingredients for higher-margin brands. Independent brands face no such constraint.

Are conglomerate-owned brands unsafe?

Products from L’Oréal, J&J, P&G, Estée Lauder, and Beiersdorf meet FDA regulatory minimums. They are not acutely dangerous. The question is not safety versus danger — the question is optimal versus adequate. These brands formulate to the minimum standard that avoids regulatory action while maximizing unit margin. Independent brands formulate to the maximum standard their mission demands.

Why do dermatologists recommend CeraVe and Cetaphil?

Pharmaceutical companies (including former J&J and current Galderma) provide product samples, educational materials, and sponsorship to dermatology practices. CeraVe and Cetaphil are the most-sampled brands in dermatology offices. Recommendation correlates with sample availability and brand familiarity, not necessarily with formulation superiority for a given patient’s needs.

Is The Ordinary actually independent?

No. The Ordinary is a brand within DECIEM, which Estée Lauder acquired majority control of in 2021 and full ownership in 2024. The Ordinary’s brand messaging about transparency and anti-markup positioning exists within and is ultimately governed by a luxury conglomerate’s strategic portfolio.

Does Era Organics compete with these companies?

Era Organics competes for the same customers — people seeking effective skincare for sensitive skin, eczema, and aging. Era Organics does not compete on advertising budget. Independent brands compete on product efficacy, ingredient transparency, and customer outcomes. The knowledge hub exists to provide the information these conglomerates’ marketing budgets work to obscure.

Where are Era Organics products manufactured?

Era Organics products are manufactured in small batches in the United States with full supply chain documentation for every ingredient. Manufacturing is not outsourced to the same contract manufacturers that produce dozens of competing brands on the same production lines.